Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Open Access
- 3 January 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-28
Abstract
Here we explored the role of interleukin-1β (IL-1β) repressor cytokine, IL-1 receptor antagonist (IL-1rn), in both healthy and abnormal hematopoiesis. Low IL-1RN is frequent in acute myeloid leukemia (AML) patients and represents a prognostic marker of reduced survival. Treatments with IL-1RN and the IL-1β monoclonal antibody canakinumab reduce the expansion of leukemic cells, including CD34+ progenitors, in AML xenografts. In vivo deletion of IL-1rn induces hematopoietic stem cell (HSC) differentiation into the myeloid lineage and hampers B cell development via transcriptional activation of myeloid differentiation pathways dependent on NFκB. Low IL-1rn is present in an experimental model of pre-leukemic myelopoiesis, and IL-1rn deletion promotes myeloproliferation, which relies on the bone marrow hematopoietic and stromal compartments. Conversely, IL-1rn protects against pre-leukemic myelopoiesis. Our data reveal that HSC differentiation is controlled by balanced IL-1β/IL-1rn levels under steady-state, and that loss of repression of IL-1β signaling may underlie pre-leukemic lesion and AML progression.Keywords
Funding Information
- Helse Nord RHF (Strategisk-HN06-14, HNF1338-17)
- Norges Forskningsråd (247596, 250901)
- Kreftforeningen (6765150)
- Erna and Olav Aakre Foundation for Cancer Research (2016/9050)
This publication has 95 references indexed in Scilit:
- Interleukin 1 Receptor Antagonist Deficiency Presenting as Infantile Pustulosis Mimicking Infantile Pustular PsoriasisArchives of Dermatology, 2012
- Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and RegenerationCell Stem Cell, 2012
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repairProceedings of the National Academy of Sciences, 2009
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtNature Protocols, 2009
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor AntagonistNew England Journal of Medicine, 2009
- Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcomeBlood, 2009
- IFNα activates dormant haematopoietic stem cells in vivoNature, 2009
- Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformationBlood, 2009
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008